Table 2.

Clinical and demographic data of IIM patients who had flare after second dose of vaccination against COVID-19, including age, gender type of vaccination, diagnosis, number of organs involved, treatment at the time of vaccination, severity of flare, type of flare, change in medication and outcome

Parameters	Patient 1	Patient 2	Patient 3	Patient 4	Patient 5	Patient 6	Patient 7
Age (years)	28	42	47	55	68	52	51
Gender (M/F)	F	F	F	F	F	M	M
Type of Vaccination	Moderna	Comirnaty	Comirnaty	Comirnaty	Comirnaty	Comirnaty	Comirnaty
Diagnosis	PM	ASS	ASS	DM	PM	PM	DM
Number of organs involved	Muscle	Skin and joint	Muscle	Muscle, skin, lung and GI	Muscle, skin, lung, heart and GI	Muscle and lung	Muscle and skin
Treatment at the time of vaccination	IVIG	GCs, MTX, RTX	MTX	GCs and MTX	MMF	RTX, Tacrolimus and GCs	GCs and MTX
Severity of flare	Mild	Mild	Major	Mild	Mild	Life-threatening	Mild
Type of flare	Muscle	Muscle	Muscle, heart and GI	Skin	Muscle	Macrophage activation syndrome	Muscle
Change in medication	No	Yes	Yes	Yes	No	Yes	No
Outcome	Resolved	Resolved	Resolved	Resolved	Resolved	Death	Resolved